clobetasol propionate 0.05 % Topical Foam
- RxCUI
- 861353
- RxNorm name
- clobetasol propionate 0.05 % Topical Foam
- Display name
- clobetasol propionate 0.05 % Topical Foam
- Full name
- clobetasol propionate 0.05 % Topical Foam
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:11
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Sun Pharmaceutical Industries, Inc. | d8f560c8-e223-46f0-8afb-b418f2b6399c | 2026-07-14 | Warnings, Adverse reactions | 861353 |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Glenmark Pharmaceuticals Inc., USA | db8c7a36-e950-44b9-b2ff-7fede2e87407 | 2026-01-29 | Warnings, Adverse reactions | 861353 |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Alembic Pharmaceuticals Limited | 6fc0d1ac-f357-4038-8004-263bfaed4eaf | 2025-04-25 | Warnings, Adverse reactions | 861353 |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Bryant Ranch Prepack | a178bb79-c0dc-4561-93df-8f7bd9d57bae | 2024-01-12 | Warnings, Adverse reactions | 861353 |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Alembic Pharmaceuticals Inc. | 0d5ca826-d200-42d8-b9c7-d05ecabb6ab2 | 2023-12-08 | Warnings, Adverse reactions | 861353 |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Padagis Israel Pharmaceuticals Ltd | 3f75880b-9ead-4c6e-b999-3bd7e1643ce5 | 2022-03-31 | Warnings, Adverse reactions | 861353 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a178bb79-c0dc-4561-93df-8f7bd9d57bae | clobetasol propionate 0.05 % Topical Foam [PSN] · clobetasol propionate 0.5 MG/ML Topical Foam [SCD] · clobetasol propionate 0.05 % Topical Foam [SY] | 3 | 101 | These highlights do not include all the information needed to use CLOBETASOL PROPIONATE FOAM safely and effectively. See full prescribing information for CLOBETASOL PROPIONATE FOAM . CLOBETASOL PROPIONATE foam, for topical use Initial U.S. Approval: 1985 | 20240112 |
| db8c7a36-e950-44b9-b2ff-7fede2e87407 | clobetasol propionate 0.05 % Topical Foam [PSN] · clobetasol propionate 0.5 MG/ML Topical Foam [SCD] · clobetasol propionate 0.05 % Topical Foam [SY] | 3 | 9 | These highlights do not include all the information needed to use CLOBETASOL PROPIONATE FOAM safely and effectively. See full prescribing information for CLOBETASOL PROPIONATE FOAM. CLOBETASOL PROPIONATE foam, for topical use Initial U.S. Approval: 1985 | 20260129 |
| 0d5ca826-d200-42d8-b9c7-d05ecabb6ab2 | clobetasol propionate 0.05 % Topical Foam [PSN] · clobetasol propionate 0.5 MG/ML Topical Foam [SCD] · clobetasol propionate 0.05 % Topical Foam [SY] | 3 | 8 | These highlights do not include all the information needed to use CLOBETASOL PROPIONATE FOAM safely and effectively. See full prescribing information for CLOBETASOL PROPIONATE FOAM. CLOBETASOL PROPIONATE foam, for topical use Initial U.S. Approval: 1985 | 20231208 |
| 3f75880b-9ead-4c6e-b999-3bd7e1643ce5 | clobetasol propionate 0.05 % Topical Foam [PSN] · clobetasol propionate 0.5 MG/ML Topical Foam [SCD] · clobetasol propionate 0.05 % Topical Foam [SY] | 3 | 7 | These highlights do not include all the information needed to use CLOBETASOL PROPIONATE FOAM safely and effectively. See full prescribing information for CLOBETASOL PROPIONATE FOAM . CLOBETASOL PROPIONATE foam, for topical use Initial U.S. Approval: 1985 | 20220331 |
| d8f560c8-e223-46f0-8afb-b418f2b6399c | clobetasol propionate 0.05 % Topical Foam [PSN] · clobetasol propionate 0.5 MG/ML Topical Foam [SCD] · clobetasol propionate 0.05 % Topical Foam [SY] | 3 | 3 | These highlights do not include all the information needed to use CLOBETASOL PROPIONATE FOAM safely and effectively. See full prescribing information for CLOBETASOL PROPIONATE FOAM. CLOBETASOL PROPIONATE foam, for topical use Initial U.S. Approval: 1985 | 20241204 |
| 6fc0d1ac-f357-4038-8004-263bfaed4eaf | clobetasol propionate 0.05 % Topical Foam [PSN] · clobetasol propionate 0.5 MG/ML Topical Foam [SCD] · clobetasol propionate 0.05 % Topical Foam [SY] | 3 | 1 | These highlights do not include all the information needed to use CLOBETASOL PROPIONATE FOAM safely and effectively. See full prescribing information for CLOBETASOL PROPIONATE FOAM. CLOBETASOL PROPIONATE foam, for topical use Initial U.S. Approval: 1985 | 20250425 |
| 797805f2-5a08-4ed3-8057-6b0b1bb08113 | clobetasol propionate 0.05 % Topical Foam [PSN] · clobetasol propionate 0.5 MG/ML Topical Foam [SCD] · clobetasol propionate 0.05 % Topical Foam [SY] | 3 | 1 | Olux ® (clobetasol propionate) Foam, 0.05% | 20120502 |
| 11054e55-9dd4-493f-8d1b-d6da7dad7ba2 | clobetasol propionate 0.05 % Topical Foam [PSN] · clobetasol propionate 0.5 MG/ML Topical Foam [SCD] · clobetasol propionate 0.05 % Topical Foam [SY] | 3 | 1 | Clobetasol Propionate Foam, 0.05% | 20110719 |